These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29800456)

  • 1. Possibility of chest wall dose reduction using volumetric-modulated arc therapy (VMAT) in radiation-induced rib fracture cases: comparison with stereotactic body radiation therapy (SBRT).
    Murakami Y; Nakano M; Yoshida M; Hirashima H; Nakamura F; Fukunaga J; Hirose TA; Yoshioka Y; Oguchi M; Hirata H
    J Radiat Res; 2018 May; 59(3):327-332. PubMed ID: 29800456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chest wall dose reduction using noncoplanar volumetric modulated arc radiation therapy for lung stereotactic ablative radiation therapy.
    Yu AS; Maxim PG; Loo BW; Gensheimer MF
    Pract Radiat Oncol; 2018; 8(4):e199-e207. PubMed ID: 29452868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.
    Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN
    Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circumferential or sectored beam arrangements for stereotactic body radiation therapy (SBRT) of primary lung tumors: effect on target and normal-structure dose-volume metrics.
    Rosenberg MW; Kato CM; Carson KM; Matsunaga NM; Arao RF; Doss EJ; McCracken CL; Meng LZ; Chen Y; Laub WU; Fuss M; Tanyi JA
    Med Dosim; 2013; 38(4):407-12. PubMed ID: 23810414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dosimetric comparison of double-arc volumetric arc therapy, step-shoot intensity modulated radiotherapy and 3D-CRT for left-sided breast cancer radiotherapy after breast-conserving surgery.
    Mo JC; Huang J; Gu WD; Gao M; Ning ZH; Mu JM; Li QL; Pei HL
    Technol Health Care; 2017 Oct; 25(5):851-858. PubMed ID: 29103057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short tangential arcs in VMAT based breast and chest wall radiotherapy lead to conformity of the breast dose with lesser cardiac and lung doses: a prospective study of breast conservation and mastectomy patients.
    Munshi A; Sarkar B; Anbazhagan S; Giri UK; Kaur H; Jassal K; Ganesh T; Kalyan Mohanti B
    Australas Phys Eng Sci Med; 2017 Sep; 40(3):729-736. PubMed ID: 28523470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
    Kannarunimit D; Descovich M; Garcia A; Chen J; Weinberg V; Mcguinness C; Pinnaduwage D; Murnane J; Gottschalk AR; Yom SS
    Technol Cancer Res Treat; 2015 Feb; 14(1):49-60. PubMed ID: 24325136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer.
    Herbert C; Kwa W; Nakano S; James K; Moiseenko V; Wu J; Schellenberg D; Liu M
    Technol Cancer Res Treat; 2013 Dec; 12(6):511-6. PubMed ID: 23617285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential reduction of lung dose via VMAT with jaw tracking in the treatment of single-isocenter/two-lesion lung SBRT.
    Pokhrel D; Sanford L; Halfman M; Molloy J
    J Appl Clin Med Phys; 2019 May; 20(5):55-63. PubMed ID: 30955251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
    Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
    J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Chest Wall Toxicity During Long-term Follow Up After Thoracic Stereotactic Body Radiation Therapy.
    Chipko C; Ojwang J; Gharai LR; Deng X; Mukhopadhyay N; Weiss E
    Pract Radiat Oncol; 2019 May; 9(3):e338-e346. PubMed ID: 30731275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of plan quality and treatment efficiency for single-isocenter/two-lesion lung stereotactic body radiation therapy.
    Sanford L; Molloy J; Kumar S; Randall M; McGarry R; Pokhrel D
    J Appl Clin Med Phys; 2019 Jan; 20(1):118-127. PubMed ID: 30548205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
    Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
    J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hybrid planning strategy for stereotactic body radiation therapy of early stage non-small-cell lung cancer.
    Liu H; Sintay B; Pearman K; Shang Q; Hayes L; Maurer J; Vanderstraeten C; Wiant D
    J Appl Clin Med Phys; 2018 Nov; 19(6):117-123. PubMed ID: 30281198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.
    Asai K; Shioyama Y; Nakamura K; Sasaki T; Ohga S; Nonoshita T; Yoshitake T; Ohnishi K; Terashima K; Matsumoto K; Hirata H; Honda H
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):768-73. PubMed ID: 22445398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
    Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
    Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique.
    Zhang GG; Ku L; Dilling TJ; Stevens CW; Zhang RR; Li W; Feygelman V
    Radiat Oncol; 2011 Nov; 6():152. PubMed ID: 22070866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
    Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
    Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.